Skip to main content
. 2014 Jun 28;18(3):R134. doi: 10.1186/cc13952

Figure 2.

Figure 2

Percentage of rehospitalization and death in all population (a); comparison of adverse events between continuous and bolus groups during 6-months follow-up period (b).